Search Results

Brian Kobilka's lab at Stanford University, USA.

Brian Kobilka , studying the dimerization of GPCRs. Dr. Kobilka’s lab contributing to the elucidation of high-resolution structures of various GPCRs. Dr.

Lefkowitz was awarded the Nobel Prize in Chemistry, shared with Brian Kobilka, for studies of G protein-coupled When Brian Kobilka proposed screening a genomic library, Merck's molecular biology collaborators called Lefkowitz and Kobilka screened it anyway. His second reaction, on learning he would share the prize with Brian Kobilka, was more personal. Brian Kobilka . Bob doesn’t really need an introduction since his reputation precedes him.

Brian Kobilka's lab at Stanford University and the SFMB laboratory at the Université Libre de Bruxelles

the beta2-adrenergic receptor (beta2AR)-G protein complex, team effort with long time collaborator Brian Kobilka .

Brian Kobilka , 2012 Nobel Laureate in Chemistry.

Brian Kobilka at Stanford University at the end of 2017 for postdoctoral work. He chose Brian's lab due to his interest in studying conformational changes. John shared his experience of reaching out to and securing a position in Brian's lab. John explained the collaborative culture in Brian's lab, where individuals are encouraged to pursue projects

Bryan Roth, Dr. Robert Lefkowitz, Dr. Fiona Marshall, Dr. Sam Hoare, Dr. Graciela Pineyro, Dr. Brian Kobilka, and many other amazing scientists. What is the format of the Dr.GPCR Podcast?

<< Back to podcast list Strategic Partner(s) Brian Shoichet About Dr. Brian Shoichet BSc in Chemistry from MIT, Ph.D. with Tack Kuntz at UCSF; Postdoc with Brian Matthews Brian Shoichet on the web Google Scholar Shoichet Lab Twitter Dr.

. << Back to podcast list Strategic Partner(s) Brian Bender: Computational Probes for Orphan GPCR The Brian Bender's work addresses this problem computationally. Brian Bender Dr. Brian is one of the organizers of the upcoming Transatlantic ECI GPCR Symposium . Dr. Brian Bender on the web LinkedIn Twitter ResearchGate Dr.GPCR Member Google Scholar Dr.

Brian Hudson About Brian Hudson Brian is a lecturer in the School of Molecular Biosciences at the University Brian Hudson on the web University of Glasgow Upcoming Live Expert Sessions ➚ 🔒Explore the Full Masterclass

. << Back to podcast list Strategic Partner(s) Brian Arey: Discovering Signaling Bias at the FSH Receptor Brian Arey, Director of Mechanistic Pharmacology at Bristol-Myers Squibb, traces the origins of that ABOUT THE GUEST Brian Arey is Director of Mechanistic Pharmacology within the Discovery and Optimization I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. Brian Arey on the web LinkedIn ResearchGate Pubmed Dr.

the mechanisms of action and regulation of hormones and neurotransmitters and how they might underlie brain Brian Kolbilka (1987) Dr. Frederik Leeb-Lundberg (1984) Dr. Robert Lefkowitz (1973) Dr.

Brian Arey on GPCR drug discovery from the inside - GPR56 mechanotransduction, the KLF2 pathway, organizational patience, and unpublished science. << Back to podcast list Strategic Partner(s) Brian Arey - Part 2: About the Guest Brian Arey is a pharmacologist and physiologist with over 25 years of pharmaceutical I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. Brian Arey on the web LinkedIn ResearchGate Pubmed Dr.

HSP90 runs opposite programs in brain and spinal cord. Block it in the brain and antinociception collapses. Brian Blagg at Notre Dame on β-and-GRP94-selective compounds has produced proof-of-concept IV data that Brian Blagg's KU-32 actually promotes neuronal survival in diabetic peripheral neuropathy and is now "The brain always wins.

Brian Shoichet at UCSF.

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

Brian Kolbika of Stanford University. Join us and learn more about Dr.

GPCR ecosystem 32:28 Q&A — preparing an episode, funding, and what's next 46:53 Recording Brian Roth "Brian throughout his career was told so many times that he should quit science.

to Scripps Research and UCSF, where he was first introduced to GPCRs and mentored by pioneers like Brian

David Hodson on visualizing GLP-1 and GIP receptors in pancreatic islets and brain circuits to advance obesity. << Back to podcast list Strategic Partner(s) Visualizing GLP-1 & GIP Receptors in Islets and Brain Professor David Hodson discusses how GLP-1 and GIP receptors regulate metabolism across the pancreas and brain Why this matters How receptor distribution in islets and brain circuits shapes incretin hormone drug

. << Back to podcast list Strategic Partner(s) Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires The brain circuits governing reward, motivation, and decision making are not fixed - Her lab investigates how GPCRs modulate synaptic transmission in brain circuits involved in reinforcement A different receptor capable of achieving the same circuit-level effect in a human brain might carry doesn't have it in a human brain.

Bryan Roth on the DARPA-funded effort to design a non-psychedelic psychedelic for depression — and why GPCR drug discovery is the biology, not the chemistry. << Back to podcast list Strategic Partner(s) Bryan Bryan leads a $26.9 Million project to create better psychiatric medications, among other things. Join me and learn more about Bryan and his work. Dr. Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project

They reviewed significant early papers related to the topic, including work by Brian Roth, Terry Kenakin

pathways to inhibit pathogen transmission, highlighting unexpected links between mosquito and human gut-brain How dissecting receptor function in non-neuronal tissues uncovers new parallels to human gut-brain communication of circadian behaviors in Drosophila , with a specific focus on how GPCR family members orchestrate brain

among the first scientists to achieve heterologous GPCR expression in mammalian cells alongside Brad Kobilka

offers real specificity - if applied carefully Fan points to the 2016 work on the mu opioid receptor by Kobilka

Instructor Andrew Tobin directs translational GPCR research focused on generating new medicines for brain

examined the role of organic cation transporter 3 (OCT3) in the regulation of monoamine signaling in the brain